Open access
148
Views
0
CrossRef citations to date
0
Altmetric
REVIEW
Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar
Dirk Deleu1 Department of Neurology (Neurosciences Institute), Hamad Medical Corporation, Doha, QatarCorrespondence[email protected]
View further author information
, View further author information
Beatriz Garcia Canibano1 Department of Neurology (Neurosciences Institute), Hamad Medical Corporation, Doha, QatarView further author information
, Osama Elalamy1 Department of Neurology (Neurosciences Institute), Hamad Medical Corporation, Doha, QatarView further author information
, Mohamed Sayed Abdelmoneim1 Department of Neurology (Neurosciences Institute), Hamad Medical Corporation, Doha, Qatarhttps://orcid.org/0000-0001-5073-6532View further author information
& Amir Boshra2 Merck Serono Middle East FZ-Ltd., Dubai, UAE, an affiliate of Merck KGaA, Dubai, United Arab EmiratesView further author information
Pages 81-88
|
Received 01 Aug 2023, Accepted 02 Nov 2023, Published online: 14 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.